bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine – Talk Bio

Actionable Insights Powered by AI

AbbVie and Simcere Zaiming Collaborate on Novel Trispecific Antibody for Multiple Myeloma Treatment

3 months ago talkbio0Tagged AbbVie, bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine, CD3 Antigens, GPRC5D, GPRC5D gene, Multiple Myeloma, Simcere, T-Lymphocyte, Trispecific Antibody, Zaiming

AbbVie, Simcere Zaiming, multiple myeloma, trispecific antibody, SIM0500, T-cell engager, GPRC5D, BCMA, CD3

Galapagos Halts BCMA CAR-T Study Due to Parkinsonism Case

9 months ago talkbio0Tagged bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine, CAR-T, Clinical Trials, Galapagos, GLPG5301, Multiple Myeloma, PAPILIO-1, Parkinsonian Disorders

Galapagos, BCMA CAR-T, Parkinsonism, multiple myeloma, CAR-T therapy, clinical trial, PAPILIO-1 study, GLPG5301